Cargando…
Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry
Surgery, chemotherapy, and radiation therapy are standard modalities for cancer treatment, but the effectiveness of these treatments has reached a plateau. Thus, other strategies are being explored to combine with the current treatment paradigms in order to reach better clinical results. One of thes...
Autores principales: | Vázquez, Ana M. H., Rodrèguez-Zhurbenko, Nely, López, Ana M. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501824/ https://www.ncbi.nlm.nih.gov/pubmed/23181219 http://dx.doi.org/10.3389/fonc.2012.00170 |
Ejemplares similares
-
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data
por: Vázquez, Ana M., et al.
Publicado: (2012) -
Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013) -
Human B-1 cells are important contributors to the naturally-occurring IgM pool against the tumor-associated ganglioside Neu5GcGM3
por: Rodriguez-Zhurbenko, Nely, et al.
Publicado: (2022) -
Anti-idiotype antibodies in cancer treatment
por: Gomez, Daniel E., et al.
Publicado: (2013) -
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
por: Segatori, Valeria I., et al.
Publicado: (2012)